Discover how the three largest pharmacy benefit managers are rejecting biosimilars from their formularies, except for their own private-label drugs.

FTC stated that the 'Big 3' PBM organisations collectively generated over £5.94 billion ($7.3 billion) in revenue from 2017 to 2022.

UnitedHealth Group has quietly but significantly scaled back its MedExpress urgent care business, with just 19 locations ...

Barnes Drug Store is an independent pharmacy in the south Georgia town of Valdosta that's been serving the community for a ...

"Given the fact that there are states, counties, cities, school districts, pension funds, and other plaintiffs from all over ...

The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.

As executives and CEOs look to beefing up their security, Todd Fox shares what his job entailed as a bodyguard to elite ...